Clorox Reports Q2 Fiscal Year 2026 Results, Confirms Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Clorox (CLX) Misses Q2 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance
February 3, 2026 4:12 PM ESTClorox (NYSE: CLX) reported Q2 EPS of $1.39, $0.05 worse than the analyst estimate of $1.44. Revenue for the quarter came in at $1.67 billion versus the consensus estimate of $1.64 billion.
GUIDANCE:
Clorox sees FY2026 EPS of $5.95-$6.30, versus the consensus of $5.95.
For earnings history and earnings-related data on Clorox (CLX) click here.
... More
